Cyclosporin in the management of polymyositis and dermatomyositis.
AUTOR(ES)
Lueck, C J
RESUMO
Three patients with polymyositis refractory to conventional steroid and immunosuppressive treatment, but responsive to cyclosporin A, are described. In a fourth patient cyclosporin A was used as a first line drug in combination with steroids in the treatment of life-threatening dermatomyositis. Cyclosporin A in the management of polymyositis/dermatomyositis requires formal assessment of its costs and benefits compared with conventional treatments.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1014627Documentos Relacionados
- Cyclosporin for dermatomyositis.
- Serum immunogloblin levels in myasthenia gravis, polymyositis, and dermatomyositis.
- Differential expression of perforin in muscle-infiltrating T cells in polymyositis and dermatomyositis.
- Preliminary observations on the role of magnetic resonance imaging for polymyositis and dermatomyositis.
- Serum myoglobin and creatine kinase concentrations in patients with polymyositis or dermatomyositis.
